GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Institutional Ownership

Arctic Bioscience AS (OSL:ABS) Institutional Ownership : 4.01% (As of Apr. 28, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Arctic Bioscience AS's institutional ownership is 4.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Arctic Bioscience AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Arctic Bioscience AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Arctic Bioscience AS Institutional Ownership Historical Data

The historical data trend for Arctic Bioscience AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Institutional Ownership Chart

Arctic Bioscience AS Historical Data

The historical data trend for Arctic Bioscience AS can be seen below:

2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30
Institutional Ownership 4.19 4.19 4.19 4.19 4.19 4.19 4.19 4.01 4.01 4.01

Arctic Bioscience AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Arctic Bioscience AS Business Description

Traded in Other Exchanges
Address
Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines